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Cells
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aDepartments of Otorhinolaryngology-Head and Neck Surgery, and Microbiology, the Tumor Virology
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ABSTRACT Helicobacter pylori and Epstein-Barr virus (EBV) are two well-known con-
tributors to cancer and can establish lifelong persistent infection in the host. This
leads to chronic inﬂammation, which also contributes to development of cancer. As-
sociation with H. pylori increases the risk of gastric carcinoma, and coexistence with
EBV enhances proliferation of infected cells. Further, H. pylori-EBV coinfection causes
chronic inﬂammation in pediatric patients. We have established an H. pylori-EBV
coinfection model system using human gastric epithelial cells. We showed that H.
pylori infection can increase the oncogenic phenotype of EBV-infected cells and that
the cytotoxin-associated gene (CagA) protein encoded by H. pylori stimulated EBV-
mediated cell proliferation in this coinfection model system. This led to increased
expression of DNA methyl transferases (DNMTs), which reprogrammed cellular tran-
scriptional proﬁles, including those of tumor suppressor genes (TSGs), through hy-
permethylation. These ﬁndings provide new insights into a molecular mechanism
whereby cooperativity between two oncogenic agents leads to enhanced oncogenic
activity of gastric cancer cells.
IMPORTANCE We have studied the cooperativity between H. pylori and EBV, two
known oncogenic agents. This led to an enhanced oncogenic phenotype in gastric
epithelial cells. We now demonstrate that EBV-driven epigenetic modiﬁcations are
enhanced in the presence of H. pylori, more speciﬁcally, in the presence of its CagA
secretory antigen. This results in increased proliferation of the infected gastric cells.
Our ﬁndings now elucidate a molecular mechanism whereby expression of cellular
DNA methyl transferases is induced inﬂuencing infection by EBV. Hypermethylation
of the regulatory genomic regions of tumor suppressor genes results in their silenc-
ing. This drastically affects the expression of cell cycle, apoptosis, and DNA repair
genes, which dysregulates their associated processes, and promotion of the onco-
genic phenotype.
KEYWORDS Epstein-Barr virus, Helicobacter pylori, epigenetics, transformation
Helicobacter pylori functions together with Epstein-Barr virus (EBV) as a group 1carcinogen which contributes to the development of gastric cancer (GC) (1, 2). EBV
is associated with several types of lymphoid and epithelial cancers, including GC (3–5).
Previous studies also suggested that EBV can transform primary gastric epithelial cells
in vitro (6). Therefore, EBV is likely not a passive carrier but an active oncogenic virus
contributing to early events in development of GC (4, 7). More importantly, EBV-positive
GC harbors EBV DNA in a uniform, monoclonal presence in all carcinoma cells (7, 8), and
patients show high antibody titers against EBV prior to diagnosis (9). In a study with
pediatric patients, coinfection with H. pylori and EBV caused severe gastritis and chronic
inﬂammation compared to individual infection of the respective pathogens (10). Fur-
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ther, many reports have highlighted the signiﬁcance of EBV and H. pylori in GC.
However, not much has been done to investigate the molecular mechanism linked to
coinfection of these agents or the degree or extent of associated pathologies, in this
case, those represented by gastric cancer.
Pathogens coexisting with host cells can act as effectors of gene regulation through
epigenetic modiﬁcations. This impacts the overall etiology and pathogenesis associated
with the respective disease. For example, the periodontal bacterium Porphyromonas
gingivalis can induce EBV reactivation through chromatin modiﬁcation (11). This
bacterium-virus synergy affects EBV-associated periodontal pathology (11). Further-
more, H. pylori and EBV have also been shown to impact epigenetic modiﬁcations of
host cells (12, 13). This relationship, which exists within the microbial milieu and
modulates host gene expression, can directly impact disease pathology.
We investigated the molecular mechanism to elucidate the underlying strategy,
which involves cooperation of H. pylori in EBV-driven proliferation of gastric epithelial
cells. We developed an H. pylori and EBV coinfection model by the use of NCI-N87
human gastric epithelial cells, which is an excellent system mimicking human gastric
epithelium (14). We demonstrated that the cytotoxin-associated gene (CagA) protein
encoded by H. pylori promoted EBV-mediated proliferation of infected cells in our
model system. Furthermore, we determined that the epigenetic status of EBV-infected
cells was modulated as a consequence of H. pylori coinfection. This reprogramming
resulted in upregulation of DNA methyl transferases (DNMTs), known epigenetic mod-
iﬁers, leading to promoter methylation of CpG-rich islands of cell cycle-, DNA repair-,
and apoptosis-related tumor suppressor genes (TSGs). Hypermethylation of the regu-
latory regions of these TSGs resulted in changes in cellular transcription proﬁles and the
microenvironment that favored oncogenesis.
RESULTS
H. pylori enhances EBV infection and virion production in human gastric
epithelial cells. The interplay between EBV and H. pylori and the downstream impli-
cations of that interplay were investigated by establishing an in vitro coinfection system
using the NCI-N87 gastric cell line, which mimics cells of the gastric epithelium (14, 15).
H. pylori and EBV cultures were established as described in Materials and Methods. As
expected, H. pylori showed regular spiral morphology by Gram stain as described earlier
(16) (see Fig. S1 in the supplemental material). We studied two possible approaches for
construction of a system using EBV and H. pylori coinfection. The ﬁrst approach was that
of simultaneous infection, where H. pylori and EBV were incubated simultaneously with
the cells (infection I), and the second was that of sequential infection, where the gastric
epithelial cells were ﬁrst incubated with H. pylori and then subjected to infection with
EBV (infection II). The results showed that sequential infection of the culture with EBV
following preincubation with H. pylori was the more effective approach, as it provided
to the cells an opportunity to establish and maintain a microenvironment suitable for
more-efﬁcient viral infection (Fig. 1A). After infection, ﬂuorescent microscopic imaging
and densitometric quantitation were performed at speciﬁc time points prior to expo-
sure of the cells with H. pylori. This method showed greater efﬁciency of infection than
simultaneous and control infections as determined by examination of green ﬂuorescent
protein (GFP) signals (Fig. 1B and C). A signiﬁcant increase in ﬂuorescence at 5 days
postinfection (dpi) as determined by densitometric analysis (Fig. 1D and E) was also
observed. Thereafter, the infection II setup was used in all of the experiments that
followed.
The relative viral copy numbers measured at 2 and 5 dpi for both cell-associated and
extracellular virion particles were signiﬁcantly and reproducibly higher during coinfec-
tion than during EBV infection alone (Fig. 1F and G). Similarly, relatively higher viral
loads were observed when the cells were exposed to H. pylori culture supernatant,
which would have contained secreted factors (Fig. S2). The level of relative density (RD)
of the GFP signal clearly showed a strong increase in efﬁciency of viral infection by 5
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FIG 1 H. pylori increases the efﬁciency of EBV infection and virion production in gastric cells. (A) NCI-N87
cells were infected with GFP-EBV with and without coinfection with H. pylori. The infection scheme is
depicted in the diagram. NCI-N87 cells were cultured in 6-well plates, and exposure to H. pylori was
performed using a transwell ﬁlter. Secretory antigens cross the transwell to which NCI-N87 cells are
exposed. EBV, being smaller than the membrane cutoff pore size, has access to the whole volume. (B)
Infection I (simultaneous infection of EBV and H. pylori). (C) Infection II. H. pylori and EBV were infected in
sequence, and preinfection of H. pylori was done for 48 h. Infection performed without H. pylori (i.e.,
infection using only EBV) and mock infection (i.e., no infection [mock]) were used as controls. The
experiment was performed three times, and images from a representative experiment are presented. (D
and E) The ﬂuorescent micrograph results were quantiﬁed using densitometric analyses, and data from the
(D) simultaneous infections and (E) sequential infections are presented as relative density (RD) values. (F
and G) Relative EBV-GFP DNA copy numbers were quantiﬁed as a measure of EBV load using (F) intracellular
and (G) extracellular released EBV in the culture and real-time qPCR.
H. pylori and EBV Cooperativity in Gastric Cancer ®
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to 7 dpi (Fig. S2A and B). Interestingly, the levels of intracellular and extracellular virions
also increased in the cells exposed to H. pylori supernatant (Fig. S2C and D).
EBV can establish two distinct modes of postinfection replication, namely, latent
replication and lytic replication. Furthermore, latent infection promotes cellular onco-
genesis. However, recent studies showed that lytic activation is also a major contributor
to the oncogenic process (17). To identify the mode of viral replication, we examined
the expression status of two EBV genes: genes EBNA1 (latent infection) and BZLF1 (lytic
infection) (Fig. 2). The results showed that the expression levels of both EBNA1 and
BZLF1 were enhanced during coinfection compared to the results seen with infection
with EBV alone as determined by immunoﬂuorescence (Fig. 2A). The transcript levels of
EBNA1 were also increased (Fig. 2B). Notably, we observed a signiﬁcant increase in the
levels of the immediate early transcript BZLF1 at 5 dpi, indicating a signiﬁcant burst of
lytic replication, early during infection. Moreover, when cells were exposed to H. pylori
prior to EBV infection, the expression levels of BZLF1 increased from 15-fold to 24-fold,
which represents a greater increase in viral lytic activity (Fig. 2C). These data validated
our ﬂuorescence data determined using the anti-BZLF1 monoclonal antibody (compare
the panels at the right side in Fig. 2A and C). Similar ﬁndings were obtained when cells
were preincubated with H. pylori culture supernatant (Fig. S3C). We found that the
expression levels of the latent EBNA1 gene and the immediate early BZLF1 gene carried
by EBV were upregulated as seen by immunoﬂuorescence upon preincubation with H.
pylori culture supernatant followed by EBV infection. Furthermore, an increase in
transcript levels was also seen for the gp350 lytic gene (Fig. S3D). These results
demonstrated that factors secreted by H. pylori are likely important in driving upregu-
lation of these virus-carried genes.
Exposure to H. pylori resulted in increased production of infectious virions in
EBV-infected gastric epithelial cells. To further support our results described above,
which showed augmentation of lytic EBV infection when cells were exposed to H. pylori
prior to EBV infection, we evaluated the viability of GFP-EBV progeny produced after
infection. Progeny of GFP-EBV were collected, ﬁltered, and used to infect a fresh culture
of NCI-N87 gastric cells. After infection, the level of GFP expression in the newly
infected cells was measured at 1, 2, and 5 dpi. As expected, the relative GFP density was
observed to be higher when infection was performed using progeny EBV collected as
described above from the supernatant obtained from coinfected NCI-N87 cells (Fig. 3A).
Interestingly, the ﬂuorescence intensity doubled after 2 dpi in the case of cells infected
with supernatant from the cultures coinfected with H. pylori and EBV (Fig. 3A). Further-
more, the virus produced from the coinfected gastric cells showed greater lytic burst
and, within 48 h postinfection, showed GFP signals that were more than two times
higher in terms of relative density than those seen with the virions produced from
gastric cells infected with EBV alone (Fig. 3B). Nevertheless, the changes in the levels of
GFP signals seen at 5 dpi were not as dramatic, but the signals from the virions
obtained from coinfected gastric epithelial cells were consistently higher (Fig. 3B).
These results showed that the ability to infect new gastric cells was enhanced in EBV
produced from gastric cells that had previously been exposed to H. pylori. Interestingly,
similar observations were recorded when, instead of H. pylori bacteria, H. pylori super-
natant or cell-free culture medium was used; the results showed enhanced levels of GFP
signals, which indicated infection of NCI-N87 cells (Fig. S4A and B). To determine if the
changes in the levels of the signals were due to passive GFP transfer, we incubated
NCI-N87 cells as described above with supernatant obtained from GFP-transfected
HEK-293 cells as a control. No passive transfer of GFP was seen in the NCI-N87 cells,
indicating that the levels of GFP signals measured in the experiments described above
were not due to passive transfer (Fig. S4C).
Acyclovir inhibits efﬁcient production of EBV progeny from gastric epithelial
cells coinfected with H. pylori. In our studies described above, we found that the
density of ﬂuorescence was signiﬁcantly higher in the coinfection model than in the
model using EBV infection alone. Using acyclovir [ACV; 9-(2-hydroxyethoxy methyl)
guanine], it was observed that there was an almost complete shutdown of signals
Pandey et al. ®
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indicating viral infection by 5 days in the infections performed with EBV alone (Fig. 3C
and D). However, in coinfection experiments performed in the presence of the antiviral
drug acyclovir, we observed a slightly higher level of signal which indicated that there
was a low level of viral infection, although this signal was about 50% lower than that
seen without the drug (Fig. 3; compare panels C and E with panels D and F). This
efﬁciency indicated that coinfection of H. pylori and EBV increased the efﬁciency of
infection by the virions produced even when replication was blocked by the inhibitor
(Fig. 3D and F).
FIG 2 H. pylori-EBV coinfection results in upregulation of EBV latent and lytic genes. (A) NCI-N87 cells were
coinfected with H. pylori-EBV-GFP along with the control. Cells were examined for the expression of latent and
lytic marker genes (EBNA1 and BZLF1, respectively) at different time points (1, 2, and 5 dpi) using ﬂuorescence
microscopy. DIC, differential interference contrast; DAPI, 4=,6-diamidino-2-phenylindole. (B to E) The expres-
sion proﬁles of EBNA1 (B), BZLF1 (C), EBNA3C (D), and gp350 (E) were analyzed at the transcript level using
RT-qPCR.
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CagA encoded by WT H. pylori is important for enhanced EBV infection of
gastric epithelial cells. Using the coinfection model described above, an H. pylori
CagA-deleted mutant [(CagA)] was evaluated for its ability to enhance EBV infection
of gastric cells (18). The progeny EBV was quantiﬁed in comparison to the results seen
with the isogenic wild-type (WT) H. pylori [H. pylori(WT)] strain. Notably, our results
showed that there was a signiﬁcant drop in efﬁciency of infection in the absence of the
CagA gene (Fig. 4A). At 2 dpi, there was little or no difference observed between EBV
coinfected with wild-type (WT) H. pylori and EBV coinfected with H. pylori(CagA). At
5 dpi, however, there was an approximately 40% drop in signal (Fig. 4A). The quanti-
FIG 3 H. pylori-EBV coinfection results in an increase of viral infectivity and is controlled by the antiviral
drug ACV. (A) Infectious virions produced in the ﬁrst coinfection and in the control experiment were
collected, and a fresh infection was set up. Then, levels of viral load and infectivity were estimated by the
use of a microscope at different time points. Data from one representative experiment are representative
of results from experiments performed in triplicate. (B) Fluorescent intensity was quantitated for the
triplicate experiments and normalized against the mock infection data, and relative expression density
data are plotted. (C and D) Microscopic analysis of GFP expression was performed in the absence (C) and
presence (D) of H. pylori (HP) by comparing the effects of 25 M ACV in both groups along with a no-ACV
control. The experiment was performed in triplicate, and data from a representative experiment are
presented. (E and F) Relative density (RD) data corresponding to GFP expression as a measure of EBV
abundance in the absence (E) and presence (F) of H. pylori were plotted after quantitation of the
ﬂuorescent intensity measured in all three experiments.
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tation of these results indicated that CagA is an important contributor to the increased
production of EBV virions and to the potency of its infection in the context of
coinfection with H. pylori (Fig. 4B). The dramatic drop in signal seen with the H. pylori
CagA mutant compared to WT H. pylori at 5 dpi was, however, greater than that seen
with EBV alone (Fig. 4B). Further studies performed using the supernatant of NCI-N87
cells after infection with EBV alone, coinfection with H. pylori(WT) and EBV, and
coinfection with H. pylori(CagA) and EBV to infect fresh gastric NCI-N87 cells showed
a dramatic drop in infection potency at 2 dpi, with some recovery at 5 dpi (Fig. S5A and
B). The GFP signal for infection was also clearly lower with the CagA mutant culture
supernatant from infected NCI-N87 cells at 5 dpi, although less than the relative density
of the signals at 2 dpi (Fig. S5B). Interestingly, the results seen after blocking early
replication using acyclovir did not show any major difference in the levels of the
resulting signals in comparisons of the results of H. pylori(WT) coinfection to the results
of H. pylori(CagA) coinfection of NCI-N87 cells with EBV. This indicated that the levels
of replication of the virions in the two coinfections in the presence of acyclovir were
inhibited to similar extents (Fig. S5; compare panels C and E with panels D and F).
H. pylori-EBV coinfection led to aberrant methylation of genes regulating
major cellular processes. In previous studies, we showed that EBV infection of primary
B cells leading to transformation relied on dysregulation of the cellular methylation
program that resulted from hijacking major cellular epigenetic modiﬁers (19, 20).
DNMTs regulate cellular epigenetic methylation patterns, including promoter hyper-
methylation of TSGs and oncogenic hypomethylation, in EBV-associated cancers (21,
22). However, the process by which H. pylori infection inﬂuences EBV-associated GC
through an epigenetics-dependent molecular mechanism has not been previously
elucidated. In this study, we investigated the relative levels of expression of DNMTs
using the coinfection model system at 1, 2, and 5 dpi using NCI-N87 gastric cells, which
mimic primary gastric epithelium cells. Upon coinfection with H. pylori and EBV, the
NCI-N87 cells were highly methylated at 2 dpi, with a signiﬁcant increase in expression
of all DNMTs examined, and the DNMTs remained induced, except for the results seen
with DNMT3L, which showed little or no detection (Fig. 5A). Further, we investigated
the promoter methylation patterns of a number of TSGs (using EpiTect methyl II PCR
arrays, without the need for bisulﬁte sequencing [SABiosciences, Frederick, MD] of the
regulatory regions of the human tumor suppressor genes), as methylation impacts the
oncogenic potential of the infected NCI-N87 cells. Our ﬁndings strongly demonstrated
that EBV infection of NCI-N87 induced promoter methylation of a number of TSGs and
FIG 4 H. pylori-encoded CagA enhances the efﬁciency of EBV infection in gastric epithelial cells. (A)
Fluorescence and phase-contrast images were captured at different time points in coinfection of EBV-GFP
along with H. pylori wild-type and CagA mutant strains. The experiment was performed in triplicate, and
data from a representative experiment are presented. (B) Relative ﬂuorescence density data were plotted
after quantiﬁcation of the results from all three experiments.
H. pylori and EBV Cooperativity in Gastric Cancer ®
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FIG 5 H. pylori and EBV coinfection alters the expression of host DNMTs, leading to hypermethylation
of TSGs, downregulation of TSG expression, and proliferation of gastric cells. (A) Gene expression analysis
of host DNA methyl transferases in response to EBV infection and H. pylori-EBV coinfection. After
infection, cell samples were collected at different time points. qPCR analysis was performed, and relative
(Continued on next page)
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that the presence of H. pylori further induced the level of methylation of these TSGs,
which are involved in cell cycle, apoptosis, and DNA damage responses (Fig. 5B, C, and
D). The hypermethylated TSGs included APC (adenomatous polyposis coli), BRCA1,
FHIT, MGMT (methyl guanine DNA methyl transferase), NEUROG1, PTEN (phosphatase
and tensin homologue), RUNX3, TP73, and VHL genes (Fig. 5B, C, and D). TSGs showing
no change in status or decreased methylation in comparisons between the results seen
with EBV infection alone and coinfection with EBV and H. pylori included the CDKN2A,
DAPK1, GSTP1, and RASSF1 genes (Fig. 5B, C, and D). A detailed description of the genes
affected by methylation reprogramming is provided in Table S1 in the supplemental
material. The complete list of 22 genes and the associated functions can be found in
Table S2.
We clustered the TSGs into distinct functional classes, and, from that analysis, we
showed that in vitro infection of the NCI-N87 gastric cells by H. pylori and EBV was
associated with transcriptional repression of a number of cell cycle genes (APC, BRCA1,
CDKN2A, FHIT, NEUROG1, PTEN, RUNX3, TP73, and VHL), genes involved in apoptosis
(BRCA1, CDKN2A, MGMT, PTEN, RUNX3, TP73, and VHL), and genes involved in DNA
damage repair (APC, BRCA1, MGMT, and TP73) (Fig. 5B, C, and D) (Table S2).
Coinfection of gastric NCI-N87 cells with H. pylori and EBV led to transcription
repression of TSGs through methylation of their promoter regulatory elements.
Exposure to carcinogens can change the methylation patterns of regulatory genes and
results in suppression of their expression (23). To support our ﬁndings indicating that
expression of DNMTs is signiﬁcantly induced during coinfection of NCI-N87 gastric
epithelial cells with H. pylori and EBV, we examined cellular genes in major functional
classes (cell cycle, apoptosis, and DNA damage repair) at the transcript level. We
performed quantitative PCR (qPCR) using experimental settings similar to those previ-
ously described (20). A detailed description of the genes examined, which were
regulated through transcriptional reprogramming, is provided in Table S3.
The results showed that coinfection with H. pylori and EBV was associated with
deregulation of cell cycle, apoptosis, and DNA damage repair genes (Fig. 5E, F, and G).
The majority of the genes investigated showed a reduction in transcript levels, except
for CDKN1 (p21), which showed increased levels, and the results are represented as a
heat map (Fig. 5E, F, and G). The TP73, VHL, APC, BRCA1, and BRCA2 genes were
downregulated, but the changes were not as dramatic, suggesting that a stringent
balance is required for their expression in NCI-N87 gastric cells coinfected with H. pylori
and EBV (Fig. 5E, F, and G). Further analysis of the associated cellular pathways using
Ingenuity pathway analysis supported our ﬁndings indicating that dysregulation of the
TSGs is likely critical for development of gastric cancer mediated by H. pylori and EBV,
as the majority of the genes that were dysregulated were connected to gastric cancer
development (Fig. S6A).
FIG 5 Legend (Continued)
transcriptional changes are presented in the form of a heat map. Expression of individual DNMTs was
normalized to the results determined for a no-infection control. The experiment was performed three
times. Min, minimum; Max, maximum. (B to D) Methyl array analysis for promoter methylation proﬁling
of TSGs of cell cycle (B), apoptosis (C), and DNA damage repair (D) pathways in response to mock
infection (Mock), EBV infection, and H. pylori–EBV coinfection in NCI-N87 cells was performed. Relative
methylation data are presented as a heat map where individual genes are normalized against mock
infection. In response to large-scale methylation of genomic DNA, the expression proﬁles of cell cycle,
apoptosis, and DNA damage repair TSGs were modulated. The levels of modulation were measured
through RT-qPCR. (E to G) Relative expression levels of cell cycle (E), apoptosis (F), and DNA damage
repair (G) TSGs were plotted as a heat map normalized against the results of mock infection. Expression
of these TSGs was mostly dampened in the case of coinfection. (H) Using the standard trypan blue
exclusion assay method, proliferation of GC cells under different conditions was scored. (I) A colony
formation assay was performed using a previously described method (68) and crystal violet staining. (J)
A model depicting the modulation of the cell cycle, apoptosis, and DNA damage repair pathways that
can lead to tumorigenesis of EBV-H. pylori-positive gastric epithelial cells. H. pylori-promoted augmen-
tation of DNMTs in host cells changes hypermethylation at the genome level and represses tumor
suppressor gene expression and therefore function. This results in an increase in the oncogenic activities
of the infected cells.
H. pylori and EBV Cooperativity in Gastric Cancer ®
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Gastric epithelial NCI-N87 cells were further exposed to H. pylori and EBV (along with
controls) to investigate their viability and proliferative activities (Fig. 5H and I). We
found that coinfection enhanced the viability of the cells as seen by trypan blue
exclusion assay and increased colony formation, as would be expected for a more
robust cancer phenotype (Fig. 5H and I). A model representing coinfection of the gastric
mucosa and the sequence of events resulting in tumorigenesis is provided (Fig. 5J). The
H. pylori(CagA) mutant showed increases similar to those seen with infection with EBV
alone (Fig. 5H and I). Importantly, the results showed that infections performed with H.
pylori(WT) and H. pylori(CagA) without EBV did not have any direct effect on the
oncogenic phenotype or on the transcript levels of the TSGs examined, indicating that
H. pylori can enhance the functional ability of EBV to drive oncogenesis but is limited
in its own capacity to drive the oncogenic phenotype of gastric epithelial cells (Fig. S6B
and C).
DISCUSSION
Oncogenesis associated with approximately 20% of human cancers is driven by
infectious agents as the causative inducers (24). Epigenetic modulators alter the
expression of cellular genes, which modiﬁes the microenvironment to one suitable for
oncogenesis. EBV is known to promote oncogenesis through epigenetic modiﬁcations
resulting in transcription reprogramming of infected cells. These changes contribute to
the development of cancers of epithelial and lymphoid origin (25, 26).
In the present study, NCI-N87 gastric epithelial cells were used; the properties of
those cells closely mimic the properties of primary gastric epithelial cells based on the
cell-cell interaction mechanisms, analysis of adherent junction, and expression of
cytoskeleton and cell-matrix proteins (14, 15). Notably, H. pylori speciﬁcally targets and
resides at the adherent junction (27, 28). This prompted us to examine a preferable
model by which EBV infection can successfully occur in H. pylori-exposed NCI-N87
gastric cells. Forty-eight hours of preincubation with H. pylori resulted in a consistently
higher EBV DNA copy number as well as in higher GFP expression with GFP-EBV–H.
pylori coinfection. Earlier studies showed that H. pylori can modulate expression of a
number of cellular genes associated with inﬂammation. Furthermore, this infection
system provided a suitable niche for EBV-driven proliferation (29, 30). Our studies
demonstrated that exposure of NCI-N87 to H. pylori prior to EBV infection signiﬁcantly
increased the efﬁciency of EBV infection and led to increased viral genome copy
numbers in the gastric epithelial cells. To determine if this was unique to NCI-N87 cells,
we replicated the coinfection experiment in AGS cells (representing another gastric
epithelial cell line), which showed similar effects (data not shown). These results
support our hypothesis that exposure to H. pylori can enhance the inﬂammatory
response which facilitates signaling activities and drives EBV-mediated proliferation of
gastric epithelial cells. Further, to address the possibility of passive GFP uptake or
enhancement of ﬂuorescence caused by dead cellular aggregates, we performed a
passive GFP uptake assay and a time course analysis post-EBV infection. The results
further validated the ﬁndings revealed by an increase in the level of GFP expression and
in viral copy numbers and indicated that the increase in the GFP signal can be caused
only by infection and virus replication. The HEK293T cells expressing GFP alone were
treated under experimental conditions similar to those used in the EBV preparation,
and culture supernatants were used for incubation with the NCI-N87 cells. The results
showed that neither dead cells nor cellular debris contributed to the GFP ﬂuorescence
observed in our experimental system.
Latent and lytic genes (EBNA1 and BZLF1 genes, respectively) displayed higher
expression than the control at increasing time points in our quantitative PCR and
immunoﬂuorescence analyses. This trend for EBNA1 and BZLF1 expression in coinfec-
tions performed with H. pylori suggests that H. pylori contributed to the increased
efﬁciency of EBV infection and to early replication. This increase in GFP expression was
most likely a direct consequence of increased levels of infection and viral replication
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leading to increased persistent production of virus particles during the early period of
infection.
Furthermore, using H. pylori cell-free culture supernatant, we were able to replicate
the results described above. This provided strong evidence that the enhanced levels of
infectivity and viral copy numbers were due to an H. pylori-encoded secretory factor.
The higher expression of latent as well as lytic genes carried by EBV and the infection
of a fresh culture of gastric epithelial cells with progeny virus suggested that the results
were the consequence of increased EBV replication in the cells in the presence of H.
pylori. Also, H. pylori coinfection resulted in a drop in viral copy numbers, although the
drop was less than that seen with EBV alone in the presence of acyclovir (ACV), which
inhibits herpesvirus replication at inhibitory concentrations (31). It should be noted that
the presence of H. pylori can alter the microenvironment of the gastric epithelial cells
and may enhance the efﬁciency of viral infection (32).
The cytotoxin-associated gene A (CagA) protein is a secretory antigen located on the
surface of H. pylori secretory vesicles (32). It forms a complex with cell junction proteins,
causing a morphological dysplastic alteration in epithelial cells (27). This alteration is
important and contributes to the oncogenic process (33). Furthermore, CagA-positive
H. pylori is associated with aggressive forms of disease, such as a severe form of
gastritis, peptic ulcers, and GC (34–36). H. pylori CagA-positive strains can also alter the
inﬂammation-driven cellular response and show increased levels of interleukin-8 (IL-8)
expression (35, 37). Our results support the hypothesis that human gastric epithelial
cells have enhanced susceptibility to EBV infection in the presence of the H. pylori
wild-type strain (carrying the CagA gene). An H. pylori CagA mutant showed a signif-
icant reduction in the level of viral infection similar to that seen with EBV alone,
suggesting that CagA was a major contributor to the increased efﬁciency of infection.
Similar observations were made with cell-free culture supernatants of the wild-type
strain and the CagA-deleted mutant, indicating that the active factor was secreted in
the culture medium. Cells have more than one mechanism for CagA uptake by gastric
cells. The ﬁrst mechanism is that of utilizing the type IV bacterial secretion system that
directly injects the CagA factor into the cells (38). Alternatively, binding of CagA to cell
surface lipid phosphatidyl serine activated integrins, and rearrangement of actin leads
to endocytosis of CagA or its fragments and causes phenotypic alteration in gastric
epithelial cells (39). Here, our results supported the hypothesis that the alternative
(second) mechanism is the one used, as the culture supernatant showed enhanced
levels of EBV infection and copy numbers.
Small-molecule effectors encoded by microbial agents can drive oncogenesis. Ad-
ditionally, interspecies competition and synergies between resident microbes can have
a signiﬁcant impact on functional outcomes. In particular, as we have observed in the
context of H. pylori and EBV dynamics in GC, phosphorylated CagA interacts with
the proto-oncogene SPH1, a host tyrosine phosphatase, and this, in turn, dampens the
CagA-induced oncogenic action (38). Conversely, EBV infection leads to promoter
hypermethylation of SPH1 which rescues the phosphorylated CagA from phosphatase
and enhances gastric oncogenesis (38). Our results add to those results and show that
TSGs are also regulated and that CagA is an important H. pylori-encoded factor.
Aberrant DNA methylation in GC is an important driver of the oncogenic process
and is associated with both H. pylori infection and EBV infection (40–42). Three major
classes of DNMTs, namely, DNMT class 1 (DNMT1) (involved in postreplication mainte-
nance of the existing methylation pattern of newly synthesized strands) and DNMT3A
and DNMT3B (DNMT3A/3B) (involved in the de novo methylation of CpGs), are impor-
tant contributors to cellular and viral methylation patterns (43). Another member of the
DNMT3 family, DNMT3L, is catalytically inactive but has a role in the development of
germ cells (44). However, binding of DNMT3L with DNMT3A/3B increases their catalytic
activity by as much as 15-fold (44). The role of DNMT2 is not completely understood;
DNMT2 is possibly associated with methylation of tRNAs and has a protective function
(45, 46). Empirical evidence indicates that the DNMTs encoded by the host cells, and
not the H. pylori-encoded DNMTs, contribute to DNA methylation of the host genome
H. pylori and EBV Cooperativity in Gastric Cancer ®
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(47). Further, more-exhaustive analysis failed to detect any H. pylori-encoded DNMTs in
the H. pylori secretory proteome (32). Here, we show that coinfection by H. pylori and
EBV induced expression of the epigenetic effectors of the host cell, including DNMTs.
Further, signiﬁcant upregulation of DNMT3A/3B led to methylation of CpG islands of
TSGs in the host genome. Notably, EBV is a known epigenetic modulator regulating a
range of cellular processes important for oncogenesis (19). In this coinfection model
system, we observed a drastic shift in the host epigenome. There are several high-
throughput methods for methylation detection, such as bisulﬁte sequencing, pyrose-
quencing, and next-generation sequencing (48–50). However, we elected to use an
EpiTect methyl II PCR array system based on the following criteria. First, it is pathway
focused and rapid; second, it is reliable, reproducible, and cost-effective. Most impor-
tantly, its outcome is comparable to those obtained using other techniques, including
bisulﬁte sequencing (51).
Upregulation of DNMTs is directly responsible for promoter hypermethylation of a
broad range of tumor suppressor genes, which in turn results in decreased expression
of TSGs (20). Further, in our current study, we showed that exposure of gastric epithelial
cells to H. pylori prior to EBV infection led to promoter hypermethylation of TSGs and
to downregulation of their transcription. This led to increased cell proliferation and an
enhanced oncogenic phenotype as seen in our colony formation assays. These results
support those of a previous study which showed that a number of TSGs had enhanced
methylation patterns in gastric cells (52).
Multiple pathways and cellular processes are affected by extensive promoter meth-
ylation of TSGs. Cyclin-dependent kinase inhibitor 2A blocks MDM2-mediated degra-
dation of p53 (53). CDKN2A interacts with MDM2 and inhibits the cytoplasm-nuclear
movement of MDM2 (53). This stabilizes p53 and enhances p53-mediated apoptosis
(53). CDKN2A also binds to E2F1 and Bcl6 and suppresses their transcription activity
(54). Downstream targets of BCL6 are proteins involved in DNA damage sensing and
cell cycle proliferation (55). CDKN1A (p21), however, was not shut down, which high-
lights its importance in the context of EBV-mediated oncogenesis (56). MGMT (methyl
guanine DNA methyl transferase) is associated with several cancer types, including
colorectal cancer, lung cancer, and glioblastoma (57). MGMT is involved in the DNA
repair process, protecting against the activity of alkylating agents, and caused the
alkylated guanidine to revert to its natural state by transferring an alkyl group to
speciﬁc cysteine residues of MGMT (57). The APC (adenomatous polyposis coli) pro-
moter is also known to be methylated in aggressive forms of breast cancer and other
cancers (58) and serves as an inhibitor of Wnt signaling (59).
Loss of the phosphatase and tensin homologue (PTEN) is associated with many
cancers and functions as a negative regulator of the PI3-kinase/AKT pathway by
downregulating PIP3 (phosphatidyl inositol 3,4,5-triphosphate) levels (60). In one study
on EBV-positive GC, PTEN was found to be hypermethylated (61). Upon infection with
recombinant EBV, GC cell lines MKN1 and MKN7 showed DNMT1 upregulation along
with hypermethylation of the regulatory region of the PTEN gene (61). This demon-
strates that the association of infection, DNMT-mediated changes in methylation of the
cellular genome, and dysregulation of cellular signaling was important for oncogenesis
(61). Another study showed that epigenetic alterations in EBV-positive GC downregu-
lated meiotic recombination protein Rec8 in 100% of the cases examined, thereby
causing loss of its tumor-suppressive effect (62). This represents a direct mechanism by
which pathogen-driven epigenetic alteration is linked to the loss of tumor suppressor
function, causing tumorigenic progression (Fig. 5).
The present study demonstrated an epigenetic mechanism which speciﬁcally in-
volved DNMT-mediated TSG silencing in infected gastric epithelial cells. It establishes
the H. pylori-EBV nexus, which creates a tumor microenvironment suitable for gastric
epithelial cell proliferation and oncogenesis. Thus, H. pylori exposure aids in prolifera-
tion of EBV-infected gastric epithelial cells through modulation of the cell cycle,
apoptosis, and DNA damage repair pathways, leading to uncontrolled proliferation of
virus-infected cells and development of gastric cancer.
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MATERIALS AND METHODS
Ethics statement. All the work was performed in accordance with ethical guidelines of University of
Pennsylvania and Helsinki recommendations.
Cells, virus, and bacterial cultures. The NCI-N87 and AGS human gastric epithelial cell lines were
obtained from the American Type Culture Collection (ATCC); the cell lines are negative for EBV (62). As
described earlier, HEK293T cells containing GFP-EBV were cultured and used for EBV ampliﬁcation (63).
Induction of virus from HEK293T cells containing GFP-EBV. Cultured 293T-GFP-EBV cells were
induced for 5 days with 20 ng/ml tetradecanoyl phorbol acetate (TPA) and 3 mM butyric acid (Sigma-
Aldrich Corp., St. Louis, MO), and the virus was puriﬁed as described previously (64).
Infection of NCI-N87 and AGS cells with GFP-EBV and H. pylori. NCI-N87 cells were grown over
poly-L-lysine-coated sterile coverslips in 6-well plates. When the cells reached 60% conﬂuence, H. pylori
exposure was set up using a 0.4-M-pore-size transwell. After 48 h, the virus was added to the culture
medium.
A primary H. pylori culture was washed twice with sterile 1 phosphate-buffered saline (PBS) and
suspended in serum- and antibiotic-free RPMI medium. Infection was performed in a 6-well plate using
a transwell system (Corning Inc., Lowell, MA) (0.4 M pore size, 24-mm diameter). NCI-N87 and AGS cells
were incubated with H. pylori for 48 h prior to the GFP-EBV treatment.
DNA and RNA extraction. DNA was isolated using a DNeasy blood and tissue kit (Qiagen, Valencia,
CA) following the manufacturer’s instructions. Extracellular viral DNA was extracted from culture super-
natants as previously described (65), and DNA was quantiﬁed using real-time quantitative PCR (RT-qPCR)
performed with previously described primers (20, 63).
Replication inhibition by ACV. Acyclovir [ACV; 9-(2-hydroxyethoxy methyl) guanine] is an antiviral.
A 25 M concentration of ACV was used for signiﬁcant and reproducible EBV replication inhibition in
NCI-N87 cells (63).
Proﬁling of DNA methylation. DNA samples obtained after infection were analyzed using human
tumor suppressor gene EpiTect DNA methylation PCR array signature panel EAHS551ZC (SABiosciences,
Frederick, MD) following the manufacturer’s instructions. Please refer to Text S1 in the supplemental
material for a detailed description of the procedure.
Real-time quantitative PCR. Real-time quantitative PCR (RT-qPCR) analysis was carried out using
previously described methods (66). Details are provided in Text S1 and elsewhere in Materials and
Methods.
Cell proliferation assay. A cell proliferation assay was performed using trypan blue exclusion and
crystal violet staining methods as previously described (67, 68). Brief descriptions are provided in
Text S1 and elsewhere in Materials and Methods.
Statistical analysis. Data were statistically analyzed using Student’s t test. All the results were
derived from triplicate experiments (***, P value of 0.001 [using Student’s t test and Graph Pad Prizm
version 6]).
Data availability. All of the data sets that support the ﬁndings of this study are available in the
present manuscript in either the main text or the supplemental material.
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